JCI online early table of contents: Nov. 16, 2009

November 16, 2009

EDITOR'S PICK: New cause of osteoporosis: mutation in a miroRNA

Many biological processes are controlled by small molecules known as microRNAs, which work by suppressing the expression of specific sets of genes. Xiang-Hang Luo and colleagues, at Second Xiangya Hospital of Central South University, People's Republic of China, have now identified a previously unknown microRNA (miR-2861) as crucial to bone maintenance in mice and humans. Of clinical importance, expression of functional miR-2861 was absent in two related adolescents with primary osteoporosis.

Several lines of evidence determined the key role of miR-2861 in maintaining bone. First, miR-2861 promoted the in vitro development of a mouse stromal cell line into the cells responsible for bone formation. Second, in mice, in vivo silencing of miR-2861 inhibited bone formation and decreased bone mass. Last, analysis of ten patients with primary osteoporosis revealed two related adolescents in whom disease was caused by a mutation in the miR-2861 precursor (pre-miR-2861) that blocked expression of miR-2861. These data led the authors to conclude that miR-2861 has an important role in controlling the generation of the cells responsible for bone formation and that defects in the processing of its precursor can cause osteoporosis.

TITLE: A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans

AUTHOR CONTACT:
Xiang-Hang Luo
Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Phone: 86-731-85292152; Fax: 86-731-85533525; E-mail: xianghangluo@21cn.com.

View this article at: http://www.jci.org/articles/view/39832?key=wTvdY50uyZkh8Uji59Po




EDITOR'S PICK: Watching Lyme disease-causing microbes move in ticks

Lyme disease is caused by the microbe Borrelia burgdorferi, which is transmitted to humans from feeding ticks. Justin Radolf and colleagues, at the University of Connecticut Health Center, Farmington, have now visualized the microbe moving through the feeding tick and determined that it has a biphasic mode of dissemination. These data provide new insight into the transmission process, detailed understanding of which is essential if new methods of preventing human infection with the Lyme disease-causing microbe are to be developed.

In this study, the midguts and salivary glands of ticks before, during, and after feeding were isolated, and the live Borrelia burgdorferi microbes imaged in real time. In the first phase of dissemination, replicating microbes formed networks of nonmotile organisms that moved by adhering to the cells lining the tick midgut. In the second phase of dissemination, the microbes became motile invasive organisms that ultimately entered the salivary glands. These data challenge the conventional viewpoint that Lyme disease-causing microbes are always motile within ticks and that this drives their dissemination.

TITLE: Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks

AUTHOR CONTACT:
Justin D. Radolf
University of Connecticut Health Center, Farmington, Connecticut, USA.
Phone: (860) 679-8480; Fax: (860) 679-1358; E-mail: jradolf@up.uchc.edu.

View this article at: http://www.jci.org/articles/view/39401?key=HnLk45JRxih3aqbS4YCQ




CARDIOLOGY: MIFfed about protection for the heart

TITLE: Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion

AUTHOR CONTACT:
Lawrence H. Young
Yale University School of Medicine, New Haven, Connecticut, USA.
Phone: (203) 785-4102; Fax: (203) 785-7567; E-mail: lawrence.young@yale.edu.

View this article at: http://www.jci.org/articles/view/39738?key=8h26RuTn7HM7U213N81F




IMMUNOLOGY: Th22 immune cell subset: a therapeutic target in chronic inflammatory skin disorders?

TITLE: Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

AUTHOR CONTACT:
Carsten B. Schmidt-Weber
National Heart and Lung Institute, Imperial College, London, United Kingdom.
Phone: 44-78-26-743-578; E-mail: c.schmidt-weber@imperial.ac.uk.

View this article at: http://www.jci.org/articles/view/40202?key=94Ifno0iLjDPD54ZjN6W




METABOLIC DISEASE: The protein MKP-1 promotes obesity-associated changes in muscle fiber type

TITLE: MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice

AUTHOR CONTACT:
Anton M. Bennett
Yale University School of Medicine, New Haven, Connecticut, USA.
Phone: (203) 737-2441; Fax: (203) 737-2738; E-mail: anton.bennett@yale.edu.

View this article at: http://www.jci.org/articles/view/39054?key=72bc5PqjImjVhlo44k05




ONCOLOGY: Targeting tumor stromal cells blocks tumor growth in mice

TITLE: Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

AUTHOR CONTACT:
Ellen Puré
The Wistar Institute, Philadelphia, Pennsylvania, USA.
Phone: (215) 898-1570; Fax: (215) 898-3937; E-mail: pure@wistar.org.

Angélica M. Santos
The Wistar Institute, Philadelphia, Pennsylvania, USA.
Phone: (215) 898-1570; Fax: (215) 898-3937; E-mail: asantos@wistar.org.

View this article at: http://www.jci.org/articles/view/38988?key=yZdblFdKB7BdGZeviwjj




CARDIOVASCULAR DISEASE: Loop the loop: speeding up a serious blood vessel condition

TITLE: An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice

AUTHOR CONTACT:
Allan R. Brasier
University of Texas Medical Branch, Galveston, Texas, USA.
Phone: (409) 772-2824; Fax: (409) 772-8709; E-mail: arbrasie@utmb.edu.

View this article at: http://www.jci.org/articles/view/38308?key=Z4esMx0R2w90OrPJDZ3u




CARDIOLOGY: A calcium current that antagonizes heart enlargement

TITLE: alpha-1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice

AUTHOR CONTACT:
Jeffery D. Molkentin
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Phone: (513) 636-3557; Fax (513) 636-5958; E-mail: jeff.molkentin@cchmc.org.

View this article at: http://www.jci.org/articles/view/39724?key=z9O2wDK4PVNLyd0m471e
-end-


JCI Journals

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.